BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

476 related articles for article (PubMed ID: 30122874)

  • 1. Nutritional issues in patients with obesity and cirrhosis.
    Schiavo L; Busetto L; Cesaretti M; Zelber-Sagi S; Deutsch L; Iannelli A
    World J Gastroenterol; 2018 Aug; 24(30):3330-3346. PubMed ID: 30122874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Considerations for bariatric surgery in patients with cirrhosis.
    Goh GB; Schauer PR; McCullough AJ
    World J Gastroenterol; 2018 Jul; 24(28):3112-3119. PubMed ID: 30065557
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Challenges and Management of Liver Cirrhosis: Practical Issues in the Therapy of Patients with Cirrhosis due to NAFLD and NASH.
    Traussnigg S; Kienbacher C; Halilbasic E; Rechling C; Kazemi-Shirazi L; Hofer H; Munda P; Trauner M
    Dig Dis; 2015; 33(4):598-607. PubMed ID: 26159280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of bariatric surgery in the management of nonalcoholic fatty liver disease and metabolic syndrome.
    Aguilar-Olivos NE; Almeda-Valdes P; Aguilar-Salinas CA; Uribe M; Méndez-Sánchez N
    Metabolism; 2016 Aug; 65(8):1196-207. PubMed ID: 26435078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional support in cirrhotic patients with sarcopenia.
    Vasques J; Guerreiro CS; Sousa J; Pinto M; Cortez-Pinto H
    Clin Nutr ESPEN; 2019 Oct; 33():12-17. PubMed ID: 31451247
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isocaloric Dietary Changes and Non-Alcoholic Fatty Liver Disease in High Cardiometabolic Risk Individuals.
    Della Pepa G; Vetrani C; Lombardi G; Bozzetto L; Annuzzi G; Rivellese AA
    Nutrients; 2017 Sep; 9(10):. PubMed ID: 28954437
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of bariatric surgery on outcomes of patients with nonalcoholic fatty liver disease: a nationwide inpatient sample analysis, 2004-2012.
    McCarty TR; Echouffo-Tcheugui JB; Lange A; Haque L; Njei B
    Surg Obes Relat Dis; 2018 Jan; 14(1):74-80. PubMed ID: 29055669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aerobic exercise training in the treatment of non-alcoholic fatty liver disease related fibrosis.
    Linden MA; Sheldon RD; Meers GM; Ortinau LC; Morris EM; Booth FW; Kanaley JA; Vieira-Potter VJ; Sowers JR; Ibdah JA; Thyfault JP; Laughlin MH; Rector RS
    J Physiol; 2016 Sep; 594(18):5271-84. PubMed ID: 27104887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Supplementation with branched-chain amino acids ameliorates hypoalbuminemia, prevents sarcopenia, and reduces fat accumulation in the skeletal muscles of patients with liver cirrhosis.
    Kitajima Y; Takahashi H; Akiyama T; Murayama K; Iwane S; Kuwashiro T; Tanaka K; Kawazoe S; Ono N; Eguchi T; Anzai K; Eguchi Y
    J Gastroenterol; 2018 Mar; 53(3):427-437. PubMed ID: 28741271
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current Prevention and Treatment Options for NAFLD.
    Wong VW
    Adv Exp Med Biol; 2018; 1061():149-157. PubMed ID: 29956213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sarcopenia impairs prognosis of patients with liver cirrhosis.
    Hanai T; Shiraki M; Nishimura K; Ohnishi S; Imai K; Suetsugu A; Takai K; Shimizu M; Moriwaki H
    Nutrition; 2015 Jan; 31(1):193-9. PubMed ID: 25441595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic Obesity in Liver Cirrhosis: Possible Mechanism and Clinical Impact.
    Nishikawa H; Enomoto H; Nishiguchi S; Iijima H
    Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Utility of transient elastography (fibroscan) and impact of bariatric surgery on nonalcoholic fatty liver disease (NAFLD) in morbidly obese patients.
    Garg H; Aggarwal S; Shalimar ; Yadav R; Datta Gupta S; Agarwal L; Agarwal S
    Surg Obes Relat Dis; 2018 Jan; 14(1):81-91. PubMed ID: 29126863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutrition Interventions for Chronic Liver Diseases and Nonalcoholic Fatty Liver Disease.
    Pimentel CF; Lai M
    Med Clin North Am; 2016 Nov; 100(6):1303-1327. PubMed ID: 27745596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liver Transplantation in the Obese Cirrhotic Patient.
    Spengler EK; O'Leary JG; Te HS; Rogal S; Pillai AA; Al-Osaimi A; Desai A; Fleming JN; Ganger D; Seetharam A; Tsoulfas G; Montenovo M; Lai JC
    Transplantation; 2017 Oct; 101(10):2288-2296. PubMed ID: 28930104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Review article: malnutrition/sarcopenia and frailty in patients with cirrhosis.
    Bunchorntavakul C; Reddy KR
    Aliment Pharmacol Ther; 2020 Jan; 51(1):64-77. PubMed ID: 31701570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Muscle contractile and metabolic dysfunction is a common feature of sarcopenia of aging and chronic diseases: from sarcopenic obesity to cachexia.
    Biolo G; Cederholm T; Muscaritoli M
    Clin Nutr; 2014 Oct; 33(5):737-48. PubMed ID: 24785098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sarcopenic obesity in fatty liver.
    Merli M; Lattanzi B; Aprile F
    Curr Opin Clin Nutr Metab Care; 2019 May; 22(3):185-190. PubMed ID: 30893090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Review article: Non-alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery.
    De Ridder RJ; Schoon EJ; Smulders JF; van Hout GC; Stockbrügger RW; Koek GH
    Aliment Pharmacol Ther; 2007 Dec; 26 Suppl 2():195-201. PubMed ID: 18081662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.